创新型同步临终关怀-透析项目的描述与结局
本研究描述了一个同步临终关怀与透析项目,该项目允许患者在接受临终关怀服务的同时接受姑息性透析。在43名入组者中,44%至少接受了一次透析治疗,56%未接受透析。所有参与者的中位临终关怀住院时间为9天(范围1-76天),接受至少一次透析治疗者的中位时间为13天(范围4-76天)。65%的入组者在家中去世,23%在住院临终关怀机构去世,12%在护理机构去世,无患者在医院去世。
要点
- 43名入组者中,44%接受了至少一次透析,56%未接受透析。
- 所有参与者中位临终关怀住院时间9天,接受透析者中位13天。
- 65%在家中去世,23%在住院临终关怀机构,12%在护理机构,无医院死亡。
核心结论
- 该项目3年经验显示,入组者的中位临终关怀住院时间长于既往报告的ESKD患者5天中位数。
- 大多数患者尽管可以选择继续透析,但未接受进一步透析治疗。
- 该经验为未来测试此类临床项目改善患者和利用结局的有效性提供了证据支持。
研究设计与样本
- 对项目入组者的 demographics、患者特征和利用情况进行的定量描述。
- 共43名入组者。
主要发现
- 43名入组者中,44%至少接受了一次透析治疗,56%未接受透析。
- 所有参与者的中位临终关怀住院时间为9天(范围1-76天),接受至少一次透析治疗者为13天(范围4-76天)。
- 血液透析的平均透析次数为3.5次(范围1-9次),腹膜透析为19.2次(范围3-65次)。
- 65%的入组者在家中去世,23%在住院临终关怀机构去世,12%在护理机构去世,无患者在醫院去世。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Compared with the general Medicare population, patients with ESKD have worse quality metrics for end-of-life care, including a higher percentage experiencing hospitalizations and in-hospital deaths and a lower percentage referred to hospice. We developed a Concurrent Hospice and Dialysis Program in which patients may receive palliative dialysis alongside hospice services. The Program aims to improve access to quality end-of-life care and, ultimately, improve the experiences of patients, caregivers, and clinicians. OBJECTIVES: We sought to describe (1) the Program and (2) enrollment and utilization characteristics of Program participants. METHODS: We conducted a quantitative description of demographics, patient characteristics, and utilization of Program enrollees. RESULTS: Of 43 total enrollees, 44% received at least one dialysis treatment, whereas 56% received no dialysis. The median (range) hospice length of stay was 9 (1-76) days for all participants and 13 (4-76) days for those who received at least one dialysis treatment. The average number of dialysis treatments was 3.5 (range 1-9) for hemodialysis and 19.2 (range 3-65) for peritoneal dialysis. Sixty-five percent of enrollees died at home, 23% in inpatient hospice, and 12% in a nursing facility; no patients died in the hospital. CONCLUSIONS: Our 3-year experience with the Program demonstrated that enrollees had a longer median hospice stay than the previously reported 5-day median for patients with ESKD. Most patients received no further dialysis treatments despite the option to continue dialysis. Our experience provides evidence to support future work testing the effectiveness of such clinical programs to improve patient and utilization outcomes.
引用
- Ernecoff NC, Bursic AE, Motter EM, et al. Description and Outcomes of an Innovative Concurrent Hospice-Dialysis Program. J Am Soc Nephrol. 2022. PMID: 35820784. doi:10.1681/ASN.2022010064
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。